Researchers presented data from the Walnut Creek, Calif.-based Providence Medical Technology's DTRAX system two-year study at Spine Week 2016 in Singapore, according to Digital Journal.
The multi-center study gathered outcomes from 53 patients with spondylotic radiculopathy who underwent cervical fusion using the DTRAX system.
Here are five takeaways:
1. Researchers found the DTRAX system reduced NDI, VAS neck pain, VAS arm pain, SF-12 PCS and SF-12 MCS.
2. The system didn't impact lordosis following surgery.
3. The radiographic fusion rate was 98.1 percent.
4. The study recorded no device failure, implant lucency or surgical re-interventions.
5. Researchers concluded DTRAX technology may be a valuable option for surgeons treating patients with cervical radiculopathy.
"We believe that DTRAX technology fills critical gaps in the continuum of traditional cervical spine care," said Jeff Smith, CEO, Providence Medical Technology.